cdk4 glutathione MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation Targeting CDK4/6 for Anticancer Therapy
Targeting CDK4 6 for Anticancer Therapy Discovery of the GSH responsive Y PROTACs targeting ALK and CDK4 6 as a potential treatment for cancer ScienceDirect CDK4 6 inhibitor mediated cell overgrowth triggers osmotic and replication stress to promote senescence: Molecular Cell Cyclin D CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation Circulation Research Therapeutic potential of CDK4 6 inhibitors in renal cell carcinoma Nature Reviews Urology
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




